In the past two years, with the continuous progress of science and technology and the strong support of various national policies, the biopharmaceutical industry has entered a stage of rapid development. Cell culture is one of the core technologies of the biopharmaceutical industry. Driven by the development of the industry, the market demand for media bottles has also ushered in growth.
Biopharmaceuticals have the characteristics of high pharmacological activity, strong specificity, good therapeutic effect and less toxic and side effects, and have already made great achievements in the global pharmaceutical market. In China, with the medical insurance coverage and continuous approval of antibody drugs, more and more biological drugs have entered the public's attention. It is estimated that the size of China's biologics market will reach 9.2 billion yuan in 2021, entering a stage of rapid development.
The development and preparation of biological drugs is inseparable from cell culture. Cultured cells require specific conditions such as temperature, pH value, osmotic pressure, carbon dioxide, etc. Among them, the role of serum (medium) is particularly important, which can provide cell growth. Adequate nutrients and provide a good growth and metabolic environment. The media bottle is made of PET raw material, with high transparency, can be stored at low temperature, and the bottle body is marked with a scale. It can not only store serum, but also is a common packaging for various solutions such as buffers, cell cryopreservatives, trypsin proteins, and culture media.
As a special packaging for serum storage, driven by the development of the industry, the market demand for serum bottles will increase, helping the biopharmaceutical industry to develop better.
The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.
The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.
In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.
Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.
NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.
In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.